Stay updated on Belvarafenib in NRAS-Mutant Melanoma Clinical Trial
Sign up to get notified when there's something new on the Belvarafenib in NRAS-Mutant Melanoma Clinical Trial page.

Latest updates to the Belvarafenib in NRAS-Mutant Melanoma Clinical Trial page
- CheckyesterdayChange DetectedThe service alert has been updated to reflect a planned maintenance period beginning on July 25th, with services expected to be unavailable for over 24 hours starting at 9 PM EDT. The revision number has also changed from v2.16.5 to v2.16.6.SummaryDifference2%
- Check8 days agoChange DetectedA service alert has been added regarding planned maintenance on July 26th, indicating that most services will be unavailable for over 12 hours starting at 6 AM EDT.SummaryDifference4%
- Check15 days agoChange DetectedThe web page has been updated to version 2.16.5, and the previous version 2.16.4 has been removed. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.SummaryDifference4%
- Check22 days agoChange DetectedThe date has been updated from March 25, 2025, to June 19, 2025.SummaryDifference0.6%
- Check29 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference3%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
Stay in the know with updates to Belvarafenib in NRAS-Mutant Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belvarafenib in NRAS-Mutant Melanoma Clinical Trial page.